Metraipolis › archive › dc_f7cff30746ce
Limited evidence of pseudoprogression following immune checkpoint inhibitor (ICI) therapy in glioblastoma — Europe PMC PMID:41613042
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41613042
- DOI
- 10.1093/noajnl/vdaf232
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T02:10:29.845Z
- SHA-256 of the archived text
bb61ee9ec5deb11a89ee8c0b91151bf969c28b32a618316f523b8f2eb5d02478- Stable URL of this page
https://metraipolis.com/documento/dc_f7cff30746ce
How to cite
Limited evidence of pseudoprogression following immune checkpoint inhibitor (ICI) therapy in glioblastoma — Europe PMC PMID:41613042 — Europe PMC (en), https://europepmc.org/article/MED/41613042 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f7cff30746ce (Metraipolis archive dc_f7cff30746ce, sha256 bb61ee9ec5deb11a89ee8c0b91151bf969c28b32a618316f523b8f2eb5d02478)
BibTeX
@misc{dcf7cff30746ce,
title = {Limited evidence of pseudoprogression following immune checkpoint inhibitor (ICI) therapy in glioblastoma — Europe PMC PMID:41613042},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41613042},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f7cff30746ce; sha256 bb61ee9ec5deb11a89ee8c0b91151bf969c28b32a618316f523b8f2eb5d02478},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41613042. Agents can read the archived copy with the MCP tool read_document.